companydata.dkEurofins BioPharma Product Testing Denmark Holding A/S: Financial statements 2025
CVR: 37064408
Eurofins BioPharma Product Testing Denmark Holding A/S (CVR 37064408) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -163,266 and a net result of DKK 8,356,614 compared with DKK -1,877,244 the year before. Equity amounted to DKK 24,787,263. The solvency ratio was 34.9%.
- Gross Profit
- -163,266 kr.
- Profit/Loss
- 8,356,614 kr.
- Equity
- 24,787,263 kr.
- Total Assets
- 71,035,676 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -163 t. | 8.4 mio. | 24.8 mio. | 0 |
| 2024 | - | -104 t. | -1.9 mio. | 16.4 mio. | - |
| 2023 | - | -93 t. | 3.6 mio. | 20.1 mio. | - |
| 2022 | - | -88 t. | 7.9 mio. | 18.8 mio. | - |
| 2021 | - | -82 t. | 4.3 mio. | 15.2 mio. | - |
Find more companies like Eurofins BioPharma Product Testing Denmark Holding A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2024. Gross profit came to DKK -103,878, and the net result was DKK -1,877,244.
About Eurofins BioPharma Product Testing Denmark Holding A/S
Eurofins BioPharma Product Testing Denmark Holding A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2015. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Stefánia Pcolová. The company is owned by Eurofins Pharma Services LUX Holding SARL. In 2025, the company reported a gross profit of DKK -163,266 and a net result of DKK 8,356,614 compared with DKK -1,877,244 the year before. Equity amounted to DKK 24,787,263.